Impact of Prophylactic β-Blocker Therapy to Prevent Stroke After Noncardiac Surgery

American Journal of Cardiology

Volumn 105, Issue 1, 2010, Pages 43-47

  van Lier, Felix ^a   Schouten, Olaf ^a   Hoeks, Sanne E ^a   van de Ven, Louis ^a   Stolker, Robert Jan ^a   Bax, Jeroen J ^b   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ATENOLOL; BISOPROLOL; CARVEDILOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LABETALOL; METOPROLOL; PROPRANOLOL;

AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ADRENERGIC BETA-ANTAGONISTS; AGED; BISOPROLOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INCIDENCE; MALE; NETHERLANDS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 72149097636     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.08.646     Document Type: Article

References (25)

1. Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery: Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335 (1996) 1713-1720
2. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., Baars H.F., Yo T.I., Trocino G., Vigna C., Roelandt J.R., van Urk H., and Dutch echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341 (1999) 1789-1794
3. Juul A.B., Wetterslev J., Gluud C., Kofoed-Enevoldsen A., Jensen G., Callesen T., Norgaard P., Fruergaard K., Bestle M., Vedelsdal R., Miran A., Jacobsen J., Roed J., Mortensen M.B., Jorgensen L., Jorgensen J., Rovsing M.L., Petersen P.L., Pott F., Haas M., Albret R., Nielsen L.L., Johansson G., Stjernholm P., Molgaard Y., Foss N.B., Elkjaer J., Dehlie B., Boysen K., Zaric D., Munksgaard A., Madsen J.B., Oberg B., Khanykin B., Blemmer T., Yndgaard S., Perko G., Wang L.P., Winkel P., Hilden J., Jensen P., and Salas N. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332 (2006) 1482
4. Yang H., Raymer K., Butler R., Parlow J., and Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152 (2006) 983-990
5. Devereaux P.J., Yang H., Yusuf S., Guyatt G., Leslie K., Villar J.C., Xavier D., Chrolavicius S., Greenspan L., Pogue J., Pais P., Liu L., Xu S., Malaga G., Avezum A., Chan M., Montori V.M., Jacka M., and Choi P. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008) 1839-1847
6. Dunkelgrun M., Boersma E., Schouten O., Koopman-van Gemert A.W., van Poorten F., Bax J.J., Thomson I.R., and Poldermans D. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 249 (2009) 921-926
7. Poldermans D., Bax J.J., Schouten O., Neskovic A.N., Paelinck B., Rocci G., van Dortmont L., Durazzo A.E., van de Ven L.L., van Sambeek M.R., Kertai M.D., and Boersma E. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 (2006) 964-969
8. US Food and Drug Administration. Maximum recommended therapeutic dose database. http://www.fda.gov/cder/Offices/OPS_IO/MRTD.htm Accessed November 6, 2009
9. Culebras A., Kase C.S., Masdeu J.C., Fox A.J., Bryan R.N., Grossman C.B., Lee D.H., Adams H.P., and Thies W. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke: a report of the Stroke Council, American Heart Association. Stroke 28 (1997) 1480-1497
10. Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikof E.L., Fleischmann K.E., Freeman W.K., Froehlich J.B., Kasper E.K., Kersten J.R., Riegel B., Robb J.F., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Buller C.E., Creager M.A., Ettinger S.M., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Hunt S.A., Lytle B.W., Nishimura R., Ornato J.P., Page R.L., Riegel B., Tarkington L.G., and Yancy C.W. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50 (2007) 1707-1732
11. Brady A.R., Gibbs J.S., Greenhalgh R.M., Powell J.T., and Sydes M.R. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
12. Lindenauer P.K., Pekow P., Wang K., Mamidi D.K., Gutierrez B., and Benjamin E.M. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
13. Lee T.H., Marcantonio E.R., Mangione C.M., Thomas E.J., Polanczyk C.A., Cook E.F., Sugarbaker D.J., Donaldson M.C., Poss R., Ho K.K., Ludwig L.E., Pedan A., and Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999) 1043-1049
14. Zaugg M., Bestmann L., Wacker J., Lucchinetti E., Boltres A., Schulz C., Hersberger M., Kalin G., Furrer L., Hofer C., Blumenthal S., Muller A., Zollinger A., Spahn D.R., and Borgeat A. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 107 (2007) 33-44
15. Anzai T., Yoshikawa T., Takahashi T., Maekawa Y., Okabe T., Asakura Y., Satoh T., Mitamura H., and Ogawa S. Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction. Cardiology 99 (2003) 47-53
16. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., Stromberg A., van Veldhuisen D.J., Atar D., Hoes A.W., Keren A., Mebazaa A., Nieminen M., Priori S.G., Swedberg K., Vahanian A., Camm J., De Caterina R., Dean V., Dickstein K., Filippatos G., Funck-Brentano C., Hellemans I., Kristensen S.D., McGregor K., Sechtem U., Silber S., Tendera M., Widimsky P., and Zamorano J.L. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29 (2008) 2388-2442
17. Redelmeier D., Scales D., and Kopp A. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ 331 (2005) 932
18. Lemaitre R.N., Heckbert S.R., Sotoodehnia N., Bis J.C., Smith N.L., Marciante K.D., Hindorff L.A., Lange L.A., Lumley T.S., Rice K.M., Wiggins K.L., and Psaty B.M. Beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke. Am J Hypertens 21 (2008) 290-296
19. Brodde O.E. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases. Fundam Clin Pharmacol 22 (2008) 107-125
20. Mialet Perez J., Rathz D.A., Petrashevskaya N.N., Hahn H.S., Wagoner L.E., Schwartz A., Dorn G.W., and Liggett S.B. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 9 (2003) 1300-1305
21. Zhou H.H., Koshakji R.P., Silberstein D.J., Wilkinson G.R., and Wood A.J. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med 320 (1989) 565-570
22. Beattie W.S., Wijeysundera D.N., Karkouti K., McCluskey S., and Tait G. Does tight heart rate control improve beta-blocker efficacy?. An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 106 (2008) 1039-1048
23. Feringa H.H., Bax J.J., Boersma E., Kertai M.D., Meij S.H., Galal W., Schouten O., Thomson I.R., Klootwijk P., van Sambeek M.R., Klein J., and Poldermans D. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 114 (2006) I344-I349
24. Kaafarani H.M., Atluri P.V., Thornby J., and Itani K.M. Beta-blockade in noncardiac surgery: outcome at all levels of cardiac risk. Arch Surg 143 (2008) 940-944
25. Bangalore S., Wetterslev J., Pranesh S., Sawhney S., Gluud C., and Messerli F.H. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 372 (2008) 1962-1976